Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma

被引：0
|
作者：
Se Hoon Park
Yuna Lee
Sang Hoon Han
So Young Kwon
Oh Sang Kwon
Sun Suk Kim
Ju Hyun Kim
Yeon Ho Park
Jeong Nam Lee
Soo-Mee Bang
Eun Kyung Cho
Dong Bok Shin
Jae Hoon Lee
机构：
[1] Department of Medicine,Division of Hematology and Oncology
[2] Gachon Medical School Gil Medical Center,Division of Gastroenterology
[3] Department of Medicine,Department of General Surgery
[4] Gachon Medical School Gil Medical Center,undefined
[5] Gachon Medical School Gil Medical Center,undefined
来源：
BMC Cancer | / 6卷
关键词：
Doxorubicin; Capecitabine; Bortezomib; Gastric Variceal Bleeding; Triplet Combination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Capecitabine-based chemotherapy for metastatic colorectal cancer
    Ling, Wei
    Fan, Jie
    Ma, Yue
    Ma, Yuan
    Wang, Hongxia
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (06) : 927 - 938
  • [42] Capecitabine in the treatment of metastatic renal cell carcinoma
    Oevermann, K
    Buer, J
    Hoffmann, R
    Franzke, A
    Schrader, A
    Patzelt, T
    Kirchner, H
    Atzpodien, J
    BRITISH JOURNAL OF CANCER, 2000, 83 (05) : 583 - 587
  • [43] Capecitabine in the treatment of metastatic renal cell carcinoma
    K Oevermann
    J Buer
    R Hoffmann
    A Franzke
    A Schrader
    T Patzelt
    H Kirchner
    J Atzpodien
    British Journal of Cancer, 2000, 83 : 583 - 587
  • [44] Capecitabine-based chemotherapy for metastatic colorectal cancer
    Wei Ling
    Jie Fan
    Yue Ma
    Yuan Ma
    Hongxia Wang
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 927 - 938
  • [45] A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer
    Yun, Jina
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (05) : 885 - 891
  • [46] Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients
    Ozdemir, N.
    Aksoy, S.
    Sendur, M. A. N.
    Akinci, M. B.
    Yazici, O.
    Budakoglu, B.
    Abali, H.
    Oksuzoglu, B.
    Zengin, N.
    JOURNAL OF BUON, 2013, 18 (04): : 831 - 837
  • [47] Prognostic Factors for Metastatic Urothelial Carcinoma Undergoing Cisplatin-based Salvage Chemotherapy
    Taguchi, Satoru
    Nakagawa, Tohru
    Hattori, Mami
    Niimi, Aya
    Nagata, Masayoshi
    Kawai, Taketo
    Fukuhara, Hiroshi
    Nishimatsu, Hiroaki
    Ishikawa, Akira
    Kume, Haruki
    Homma, Yukio
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (09) : 923 - 928
  • [48] AntineoplasticsNasopharyngeal stenosis (first report with capecitabine, cisplatin and doxorubicin): 2 case reports
    Reactions Weekly, 2008, 1187 (1) : 7 - 7
  • [49] Cytotoxic Chemotherapy as an Alternative for Systemic Treatment of Advanced Hepatocellular Carcinoma in Developing Countries
    Abouelezz, Khaled
    Khanapara, Dipen
    Batiha, Gaber El-Saber
    Ahmed, Esraa A.
    Hetta, Helal F.
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 12239 - 12248
  • [50] Systemic Cytotoxic Chemotherapy of Patients With Advanced Hepatocellular Carcinoma in the Era of Sorafenib Nonavailability
    Yoon, Eileen L.
    Yeon, Jong Eun
    Lee, Hyun Jung
    Suh, Sang Jun
    Lee, Sun Jae
    Kang, Seong Hee
    Kang, Keunhee
    Yoo, Yang Jae
    Kim, Ji Hoon
    Yim, Hyung Joon
    Byun, Kwan Soo
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2014, 48 (03) : E22 - E29
12345